CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. CRISPR-Cas9 system is being used in microbial genome editing, mammalian genome editing, disease models, and more. It has shown potential in human disease treatment. However, it is not easy to find CRISPR-Cas systems genome editing in a single source.This volume offers CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease, fungal disease, stem cell therapy, CRISPR in epigenetics, CRISPR in cancer, autoimmune and blood disorders. In addition, it highlights a number of aspects of the CRISPR-Cas systems that can help the basic understanding of students, researchers, clinicians, entrepreneurs, and stakeholders to perform their research with great interest. Updares on CRISPR-Cas systems for human diseases, bacterial disease, gut microbiome editing, viral disease, protozoan disease and fungal diseaseDiscusses stem cell therapy, CRISPR in epigenetics, CRISPR in cancer, autoimmune and blood disordersIncludes commentary on CRISPR in autoimmune and blood disorders INDICE: 1. Advances in CRISPR-Cas systems for human diseasesVijai Singh2. Advances in CRISPR -Cas systems for human bacterial diseaseIndra Mani3. Advances in CRISPR-Cas systems for gut microbiomeIndra Mani4. Recent progress in CRISPR -Cas systems for human viral diseaseVijai Singh5. Recent development in CRISPR -Cas systems for human protozoan diseasesABHISHEKA BANSAL, Utkarsh Gangwar, Himashree Choudhury and Risha Shameem6. Advances in CRISPR -Cas systems for fungal infectionsAjay Kumar I7. Advances in CRISPR-Cas systems based cell and gene therapyAparna Jayachandran and Arpita Poddar8. Advances in CRISPR-Cas systems for epigeneticsMustafeez Mujtaba Babar, Mahnoor Ilyas, Alvina Gul and Jayakumar Rajadas9. Current progress in CRISPR -Cas systems for cancerMustafeez Mujtaba Babar, Hajra Ali, Hunaiza Fatima, Alvina Gul and Jayakumar Rajadas10. Current progress in CRISPR -Cas systems for autoimmune diseasesAjay Kumar I11. Advances in CRISPR -Cas systems for blood disordersDeepak balaji Thimiri govindaraj and Mutsa Monica Takundwa
- ISBN: 978-0-443-31588-6
- Editorial: Academic Press
- Encuadernacion: Cartoné
- Páginas: 300
- Fecha Publicación: 01/10/2024
- Nº Volúmenes: 1
- Idioma: Inglés